William Blair assumed coverage of Enovis (ENOV) with an Outperform rating. The firm believes the stock’s valuation reflects investor skepticism. Enovis’ execution on free cash flow improvement will be the most important driver of multiple expansion from current levels, the analyst tells investors in a research note. William Blair thins the company has set a more conservative bar with its 2026 underlying growth guidance at 4%-6%. It sees fair value for the shares in the low to mid-$30s 12 months out.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV:
- Enovis price target lowered to $39 from $43 at BTIG
- Enovis price target lowered to $35 from $36 at Evercore ISI
- Enovis assumed with an Overweight at Wells Fargo
- AI Reliance Raises Operational, Regulatory, and Reputational Risks for Enovis Corporation
- Enovis Corp Earnings Call Highlights Growth and Cash